Cancer clinical investigators should converge with pharmacometricians Editorial

  


Authors: Maitland, M. L.; O'Cearbhaill, R. E.; Gobburu, J.
Title: Cancer clinical investigators should converge with pharmacometricians
Abstract: The applied quantitative science pharmacometrics has significantly enhanced cancer therapeutics development. Pharmacometrics is now improving our understanding of complex diagnostics. Through the concept of convergence and methods of quantitative and systems pharmacology, pharmacometrics is poised to interconnect mathematical models of disease and therapy to advance cancer care. © 2019 American Association for Cancer Research.
Journal Title: Clinical Cancer Research
Volume: 25
Issue: 17
ISSN: 1078-0432
Publisher: American Association for Cancer Research  
Date Published: 2019-09-01
Start Page: 5182
End Page: 5184
Language: English
DOI: 10.1158/1078-0432.Ccr-19-1067
PUBMED: 31248883
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071784007&doi=10.1158%2f1078-0432.CCR-19-1067&partnerID=40&md5=aca4df9ff8d0399fb55ff104d2bf661e
Notes: Article -- Export Date: 1 October 2019 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Roisin Eilish O'Cearbhaill
    271 O'Cearbhaill
Related MSK Work